I now have comprehensive information from multiple authoritative textbooks. Let me compile the full answer.
Perioperative Myocardial Infarction (PMI)
Perioperative myocardial infarction is one of the most serious complications of noncardiac surgery, carrying mortality as high as 70% in severe cases. It encompasses both classic MI and the broader entity of myocardial injury after noncardiac surgery (MINS).
Definition
PMI is defined as myocardial ischemia/necrosis occurring in the perioperative period (intraoperatively or within the first 48-72 hours postoperatively). A key challenge: 65% of patients with PMI are completely asymptomatic (POISE trial data). MINS specifically refers to a perioperative increase in high-sensitivity cardiac troponin (hsTnT) of ≥14 ng/L from preoperative baseline, even without ischemic symptoms. - Miller's Anesthesia, 10e, p. 9148
Incidence
- Following cardiovascular surgery: 7%-19%
- Orthopedic patients (total hip/knee replacement): ~20%
- Spinal surgery: ~15%
- 93% of MINS cases are entirely silent (no symptoms)
- 30-day mortality with MINS: up to 9%; 1-year mortality: up to 22%
- Barash Clinical Anesthesia, 9e; Miller's Anesthesia, 10e
Pathophysiology - Two Mechanisms
Type I - Plaque Rupture and Thrombosis
The surgical stress state triggers:
- Catecholamine surges causing coronary vasoconstriction
- Pro-inflammatory and pro-thrombotic states
- Platelet activation and hypercoagulability
- These forces act on vulnerable plaques, causing rupture and acute occlusion
Type II - Supply-Demand Imbalance
Perioperative alterations that reduce oxygen delivery or increase demand:
- Hypoxia, anemia, hypotension (reduce supply)
- Tachycardia, hypertension, hypothermia (increase demand)
- High peak intraoperative HR >100 bpm is specifically associated with myocardial injury and perioperative mortality
- Lowest intraoperative HR <55 bpm is also associated with worse outcomes
Both mechanisms can coexist. The surgical sympathetic stress response, inflammation, and neuroendocrine activation combine to create a "vulnerable blood" state, especially after cardiac surgery. - Sabiston Textbook of Surgery; Barash Clinical Anesthesia, 9e
Genetic Susceptibility
Polymorphisms in pro-inflammatory genes (IL-6, IL-1, ICAM-1, TNFA, E-selectin) modulate individual susceptibility to perioperative myocardial injury. Polygenic risk scores (PRS-CAD) independently associate with MINS. - Barash Clinical Anesthesia, 9e
Timing
Most PMI events occur within 48 hours after surgery. Risk of AMI is markedly elevated in the first few weeks postoperatively (demonstrated for orthopedic procedures by large national cohort data). - Miller's Anesthesia, 10e
Clinical Features
Symptoms (when present):
- Substernal chest pain/pressure, possibly radiating to left shoulder or neck
- Dyspnea, diaphoresis, tachycardia
- Arrhythmias
- Signs of heart failure, hypoxia, or acidosis
- Cardiogenic shock, cardiac arrest (severe cases)
Recall: most patients are asymptomatic - biomarker surveillance is the primary detection strategy in high-risk patients.
Diagnosis
| Tool | Findings |
|---|
| ECG | ST elevation, ST depression, T-wave inversions, new Q waves |
| Cardiac biomarkers | Troponin (preferred), CK-MB; may be the only abnormality in asymptomatic cases |
| Echocardiography | New regional wall motion abnormality, LV dysfunction |
| High-sensitivity troponin (hsTnT) | Elevated postoperative levels predict 30-day mortality even without ischemic features |
AHA/ACC guidelines recommend obtaining troponin for all patients with post-op ECG changes or typical ischemic chest pain.
Canadian Cardiovascular Society Guidelines recommend daily troponin measurements for 48-72 hours after noncardiac surgery in high-risk patients. - Miller's Anesthesia, 10e
Risk Stratification
Revised Cardiac Risk Index (RCRI) - Lee Index
The most commonly used tool. Two or more risk factors = elevated risk:
| RCRI Predictor |
|---|
| High-risk surgery (intraperitoneal, intrathoracic, suprainguinal vascular) |
| History of ischemic heart disease |
| History of congestive heart failure |
| History of cerebrovascular disease |
| Insulin-dependent diabetes |
| Preoperative serum creatinine >2 mg/dL |
Gupta MICA Calculator
Derived from ACS-NSQIP data; predicts intraoperative or postoperative MI and cardiac arrest using: type of surgery, functional status, serum creatinine, ASA class, and age. Validated in multiple populations. - Sabiston Textbook of Surgery
AUB-HAS2 Cardiovascular Risk Index
Six predictor variables: history of heart disease, symptoms of heart disease (angina or dyspnea), age ≥75, anemia (Hgb <12 g/dL), vascular surgery, emergency surgery. Validated using ACS-NSQIP. - Sabiston Textbook of Surgery
Prevention
Preoperative
- Cardiac evaluation - ECG within 3 months before surgery; assess LV function in patients with unknown dyspnea or change in functional class
- Delay elective surgery after PCI/stenting:
- Low thrombotic risk: 4 weeks after balloon angioplasty
- 6 months after bare metal stent
- 1 year after drug-eluting stent
- Continue aspirin and statins perioperatively in patients already on them
- Correct anemia to optimize oxygen delivery
Beta-Blockers
- Continue in patients already taking them - do NOT abruptly stop
- Consider initiating in high-risk patients (RCRI ≥3) several days before surgery
- Evidence from POISE trial: beta-blockers reduce MI risk but increase stroke and hypotension risk if started acutely
Dual Antiplatelet Therapy (DAPT) Management
Balance thrombotic vs. hemorrhagic risk. Specific ACC/AHA guidelines exist; surgeon judgment required for individualization. - Sabiston Textbook of Surgery
Management Once PMI Occurs
The distinction between Type I and Type II is critical because management differs:
Type I PMI (Plaque Rupture/Thrombosis)
- Aspirin - aggressive therapy (balance bleeding risk)
- Statin therapy
- Beta-blockers (secondary prevention, when feasible)
- ACE inhibitors (when feasible)
- Coronary angiography - strongly consider
- PCI or surgical revascularization - risk-benefit must weigh recent surgical bleeding risk
Type II PMI (Supply-Demand Imbalance)
- Optimize hemodynamics (correct hypotension, treat hypertension)
- Optimize oxygenation (treat anemia, supplemental O2)
- Rate control (treat tachycardia)
- Coronary angiography during follow-up after surgery
General Measures (Both Types)
- Immediate cardiology consult; notify primary surgical team
- Optimize blood pressure, heart rate, oxygenation
- Nitroglycerin, beta-blocker, statin, aspirin (if no absolute contraindications)
- Treat pain with opioids; correct anemia
- Code cart availability; point-of-care ultrasonography or formal echocardiography
- Fibrinolysis, PCI, or revascularization - multidisciplinary decision between surgeon, cardiologist, anesthesiologist, and patient
- IABP if cardiogenic shock
Median time from PMI to death is approximately 12 days. - Sabiston Textbook of Surgery
Life-Threatening Mechanical Complications
| Complication | Notes |
|---|
| Free wall rupture | Catastrophic; near-universal mortality without emergency surgery |
| Ventricular septal defect (VSD) | Acute shunt; requires surgical repair |
| Acute mitral regurgitation | Rupture of papillary muscle or chordae tendineae |
| Complete heart block | May require emergency pacing |
| Cardiogenic shock | Intra-aortic balloon pump, vasopressors, urgent revascularization |
Overall mortality in the group with severe PMI complications: up to 70%. - Sabiston Textbook of Surgery
Key Sources
- Sabiston Textbook of Surgery, 21e, Chapter 26 - Perioperative Myocardial Ischemia and Infarction
- Miller's Anesthesia, 10e, Chapter 60 - Coronary Artery Disease (Orthopedic patients / PMI)
- Miller's Anesthesia, 10e, Chapter on PACU Management / Treatment
- Barash, Cullen & Stoelting's Clinical Anesthesia, 9e, Chapter 6 - Perioperative Myocardial Infarction and Ventricular Dysfunction